CDKN2A-p53 mediated antitumor effect of Lupeol in head and neck cancer.
about
Identification of novel gene expression signature in lung adenocarcinoma by using next-generation sequencing data and bioinformatics analysis.Fibroblast growth factor receptor 1 and 3 expression is associated with regulatory PI3K/AKT kinase activity, as well as invasion and prognosis, in human laryngeal cancer.
P2860
CDKN2A-p53 mediated antitumor effect of Lupeol in head and neck cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
CDKN2A-p53 mediated antitumor effect of Lupeol in head and neck cancer.
@en
CDKN2A-p53 mediated antitumor effect of Lupeol in head and neck cancer.
@nl
type
label
CDKN2A-p53 mediated antitumor effect of Lupeol in head and neck cancer.
@en
CDKN2A-p53 mediated antitumor effect of Lupeol in head and neck cancer.
@nl
prefLabel
CDKN2A-p53 mediated antitumor effect of Lupeol in head and neck cancer.
@en
CDKN2A-p53 mediated antitumor effect of Lupeol in head and neck cancer.
@nl
P2093
P2860
P1433
P1476
CDKN2A-p53 mediated antitumor effect of Lupeol in head and neck cancer.
@en
P2093
Anup K Bhowmick
Biswanath Majumder
Debapriya G Mehrotra
Gautam K Mandal
Jaydip Biswas
Nabendu Murmu
Neyaz Alam
Pradip K Majumder
Samir Banerjee
Sayantan Bhattacharyya
P2860
P2888
P304
P356
10.1007/S13402-016-0311-7
P577
2016-12-30T00:00:00Z